You are viewing: Europe Nuclear Medicine Equipment Market analysis

The Europe Nuclear Medicine Equipment Market was valued at $1712.8 Million in 2025 and projected to reach to $2157.1 Million by 2030, representing a compound annual growth rate of 4.7%. Europe's nuclear medicine equipment market is positioned for sustained growth driven by an aging population, increasing chronic disease prevalence, and continued healthcare modernization across the region.

Europe Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Nuclear Medicine Equipment Market Trends and Insights

  • This steady growth reflects Europe's advanced healthcare infrastructure, aging population, and increasing prevalence of chronic diseases requiring diagnostic imaging.
  • Europe maintains a mature market with strong regulatory frameworks and established reimbursement pathways that support equipment adoption across hospitals and diagnostic centers. The European market benefits from significant investments in healthcare modernization and the integration of hybrid imaging technologies such as PET/CT and SPECT/CT systems.
  • Europe's emphasis on precision medicine and early disease detection drives demand for advanced nuclear medicine equipment.
  • Key markets within Europe, including Germany, France, and the United Kingdom, continue to upgrade their nuclear medicine capabilities to meet clinical demand and improve patient outcomes through enhanced diagnostic accuracy..

Key Market Statistics

  • CAGR (2025-2030) 4.7% CAGR
  • Market Size, 2025 ~USD 1712.8 Million
  • Forecast, 2030 ~USD 2157.1 Million
  • Geography Europe

Europe Nuclear Medicine Equipment Market Overview

Market Leadership by Germany :

Germany dominates Europe's nuclear medicine equipment market with a valuation of $633.4 million in 2025, driven by advanced healthcare infrastructure, strong medical device manufacturing capabilities, and high adoption of diagnostic imaging technologies.

Aging Population Driving Demand :

Europe's rapidly aging demographic is a key growth catalyst, with increasing prevalence of cancer, cardiovascular diseases, and neurological disorders requiring nuclear medicine diagnostics and therapeutic interventions across the region.

Regulatory Excellence and Standardization :

Stringent EU regulatory frameworks and CE marking requirements ensure high-quality equipment standards, fostering market trust and enabling European manufacturers to maintain competitive advantages in diagnostic accuracy and patient safety.

Steady 4.7% CAGR Through 2030 :

Europe's nuclear medicine equipment market is projected to grow from $1,712.8 million in 2025 to $2,157.1 million by 2030, reflecting consistent investment in healthcare infrastructure and modernization of diagnostic imaging facilities.

Europe Nuclear Medicine Equipment Market Dynamics

  • Strong regulatory frameworks and established reimbursement policies support steady adoption of advanced diagnostic imaging technologies.
  • Germany, France, and the UK lead market expansion, while emerging healthcare investments in Central and Eastern European countries present additional growth opportunities. The market outlook remains positive as European healthcare systems prioritize early disease detection and personalized medicine approaches.
  • Technological advancements in hybrid imaging systems (PET/CT, SPECT/CT) and growing clinical applications in oncology, cardiology, and neurology will drive equipment replacement cycles and new facility installations through 2030..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Europe's nuclear medicine equipment market will grow from $1,712.8M (2025) to $2,157.1M (2030) at a 4.7% CAGR.
    • Europe's mature healthcare infrastructure and aging population support sustained demand for diagnostic imaging equipment.
    • Hybrid imaging technologies and precision medicine initiatives are key growth drivers across European markets.
    • Strong regulatory frameworks and reimbursement policies in Europe facilitate equipment adoption and market expansion.

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    Europe Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    REST OF EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    CANCER TREATMENT CENTERS34.936.53839.741.443.144.946.84.2
    DIAGNOSTIC IMAGING CENTERS5961.964.767.770.874.177.480.84.5
    HOSPITALS164.4170.9177.5184.2191.1198.2205.5212.93.7
    OTHER END USERS28.529.630.631.732.833.93536.23.4
    TOTAL286.9298.8310.9323.3336.1349.3362.9376.83.9

    EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    CANCER TREATMENT CENTERS206216.8228239.7251.9264.7278291.95.1
    DIAGNOSTIC IMAGING CENTERS329.3347.6366.4386.3407.1428.9451.6475.55.3
    HOSPITALS874.3915.3957.310011046.51093.71142.51193.34.5
    OTHER END USERS148.2154.6161.1167.8174.6181.7189196.54.1
    TOTAL1557.91634.31712.81794.71880.11968.92061.12157.14.7

    Target Audience

    • Medical Device Manufacturers : Manufacturers of nuclear medicine equipment need Europe-specific market data to identify growth opportunities, assess competitive positioning, optimize product portfolios, and plan regional manufacturing and distribution strategies.
    • Healthcare Facility Operators : Hospital networks, diagnostic imaging centers, and nuclear medicine departments require market insights to justify capital equipment investments, benchmark utilization rates, and plan facility modernization initiatives.
    • Investment and Private Equity Firms : Investors evaluating healthcare technology companies and medical device portfolios need Europe market analysis to assess growth potential, valuation multiples, and strategic acquisition opportunities in the nuclear medicine sector.
    • Healthcare Consultants and Advisors : Management consulting firms and healthcare advisors utilize regional market data to support client strategy development, market entry planning, and competitive analysis for nuclear medicine equipment stakeholders.
    • Regulatory and Policy Bodies : Healthcare regulators, government agencies, and policy makers use market intelligence to inform reimbursement policies, healthcare infrastructure planning, and technology adoption guidelines across European member states.

    Key Companies in the Europe Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 3555.6 Million · 4.4% wtd CAGR ·
    Asia Pacific
    ~USD 1938.2 Million · 5.2% wtd CAGR ·
    Latin America
    ~USD 287.8 Million · 3.5% wtd CAGR ·
    Middle East & Africa
    ~USD 372.1 Million · 3.8% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 633.4 Million
    UKUSD 346 Million
    FranceUSD 422.7 Million
    ItalyUSD 181.9 Million
    SpainUSD 146 Million
    SwedenUSD 50.2 Million
    Rest Of EuropeUSD 376.8 Million

    Country market size visualization

    Germany
    USD 633.4 Million
    UK
    USD 346 Million
    France
    USD 422.7 Million
    Italy
    USD 181.9 Million
    Spain
    USD 146 Million
    Sweden
    USD 50.2 Million
    Rest Of Europe
    USD 376.8 Million

    Reasons to Buy this Report

    • Country-Level Market Segmentation : Access detailed market sizing for Germany ($633.4M), France ($422.7M), UK ($346M), Italy ($181.9M), Spain ($146M), and Sweden ($50.2M), enabling precise regional investment and expansion strategies.
    • Competitive Landscape Intelligence : Understand market dynamics across Europe's mature healthcare systems, identify leading manufacturers, and benchmark performance against regional competitors to optimize market positioning and pricing strategies.
    • Growth Opportunity Identification : Leverage 4.7% CAGR projections and demographic trends to identify high-potential markets for equipment sales, service expansion, and technology partnerships across Western and emerging Eastern European regions.
    • Regulatory and Reimbursement Insights : Gain comprehensive understanding of EU regulatory requirements, CE marking processes, and country-specific reimbursement policies that impact market entry, product positioning, and revenue forecasting.
    • Strategic Planning and Forecasting : Utilize 2025-2030 market projections and CAGR analysis to develop long-term business strategies, capital allocation plans, and market expansion roadmaps tailored to Europe's healthcare infrastructure evolution.

    Frequently asked questions

    What is the current size of Europe's nuclear medicine equipment market?

    Europe's nuclear medicine equipment market is valued at $1,712.8 million in 2025.

    What is the projected market size for Europe by 2030?

    Europe's nuclear medicine equipment market is projected to reach $2,157.1 million by 2030.

    What is the growth rate for Europe's nuclear medicine equipment market?

    Europe's nuclear medicine equipment market is expected to grow at a compound annual growth rate of 4.7% from 2025 to 2030.

    Which countries drive the largest share of Europe's nuclear medicine equipment market?

    Germany, France, and the United Kingdom are among the key markets driving growth in Europe's nuclear medicine equipment sector.

    What factors support growth in Europe's nuclear medicine equipment market?

    Europe's advanced healthcare infrastructure, aging population, hybrid imaging technology adoption, and strong reimbursement policies support market growth.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status